Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  KARACHI STOCK EXCHANGE (GUARANTEE) LIMITED, THE  >  Searle Co Ltd    SEAR   PK0061701014

SEARLE CO LTD (SEAR)
My previous session
Most popular
  Report  
No quotes available
-- PKR   --.--%
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Searle : Another Research and Development Centre opens at KU

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 08:16pm CEST

Research and Development (R and D) Centre of the country’s famous pharmaceutical company, The Searle Company Limited (TSCL) was inaugurated at the ICCBS Technology Park and Technology Incubation Centre, University of Karachi (UoK) on Thursday.

Prof. Atta-ur-Rahman, former Federal Minister of Science and Technology, and former Chairman HEC, Chief Executive Officer TSCL Syed Nadeem Ahmed, and Director ICCBS Prof. Dr. Mohammad Iqbal Choudhary jointly uncovered the curtain of a plaque fixed at the building of the ICCBS technology park. On the occasion, international guests, attending the MMDR Symposium at ICCBS, were also present.

Expressing their views on the occasion, Prof. Atta-ur-Rahman said that the establishment of the research and development center will significantly accelerate the development, and release of national innovative pharmaceutical to the market. He said the launch of the modern R and D Centre was an important step to develop the healthcare and Pharmaceutical industry, which on the one hand is an indicator of the state social and economic development and on the other hand will support effective academia-industry linkage. Syed Nadeem Ahmed appreciated the efforts of the ICCBS for taking the right step to develop the linkages between industry and academia.

Prof. Iqbal Choudhary welcomed the guests and foreign visitors, and said it was a great moment for the international center and Searle to work together on the development of new drugs and biological for common people. He said that both organizations had already made an agreement to collaborate in the areas of bioequivalence studies and clinical trial projects to strengthen the pharmaceutical industry. Bioequivalence studies are very important for the development of a pharmaceutical preparation in the pharmaceutical industry, he said. Other officials of the ICCBS and higher-ups of the company also attended the opening ceremony.

(c) 2017 Pakistan Press International (PPI). All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SEARLE CO LTD
08/10SEARLE : Quarterly Progress Report for the Period Ended June 30, 2018 Utilizatio..
AQ
07/26RECALL PROCESS OF BATCHES OF ANTIHYP : DRAP - Press Note issued by Press Informa..
AQ
07/25SEARLE : DRAP asks manufactures using API to ensure aviability of their product
AQ
07/25API MANUFACTURED ANTIHYPERTENSIVE ME : Drap
AQ
07/25RECALL PROCESS OF BATCHES OF ANTIHYP : DRAP - Press Note issued by Press Informa..
AQ
04/28SEARLE : Financial results of The Searle Company Limited for Quarter ended March..
AQ
04/28EARNINGS REPORT : Searle declares EPS Rs3.4 for 3QFY18, down 32 per cent QoQ
AQ
04/20SEARLE : Board of Directors meeting of The Searle Company Limited
AQ
04/13Loss of Shares
AQ
02/28SEARLE : Financial results of The Searle Company Limited for Quarter ended Decem..
AQ
More news
Financials (PKR)
Sales 2018 15 723 M
EBIT 2018 3 733 M
Net income 2018 -
Debt 2018 -
Yield 2018 2,97%
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales 2018 3,95x
Capi. / Sales 2019 3,25x
Capitalization 62 109 M
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 429  PKR
Spread / Average Target 28%
Managers
NameTitle
Syed Nadeem Ahmed Chief Executive Officer, Executive Director & MD
Adnan Asdar Ali Chairman
Mobeen Alam Chief Financial Officer & Finance Director
Imtiaz Haider Director-Technical Operations
Rashid Abdulla Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SEARLE CO LTD501
JOHNSON & JOHNSON-3.76%360 750
PFIZER16.21%246 736
NOVARTIS0.10%211 093
ROCHE HOLDING LTD.-2.66%208 211
MERCK AND COMPANY22.73%183 667